These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35956925)

  • 21. SARS-CoV-2 and influenza: a comparative overview and treatment implications.
    Manzanares-Meza LD; Medina-Contreras O
    Bol Med Hosp Infant Mex; 2020; 77(5):262-273. PubMed ID: 33064680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro.
    Jonsdottir HR; Siegrist D; Julien T; Padey B; Bouveret M; Terrier O; Pizzorno A; Huang S; Samby K; Wells TNC; Boda B; Rosa-Calatrava M; Engler OB; Constant S
    Biomed Pharmacother; 2022 Jun; 150():113058. PubMed ID: 35658229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Hudecová IMJČGKMPL
    Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precision therapeutic targets for COVID-19.
    Krumm ZA; Lloyd GM; Francis CP; Nasif LH; Mitchell DA; Golde TE; Giasson BI; Xia Y
    Virol J; 2021 Mar; 18(1):66. PubMed ID: 33781287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical efficacy and safety of novel SNAT against SARS-CoV-2 using a hamster model.
    Pokhrel LR; Williams F; Cook PP; O'Rourke D; Murray G; Akula SM
    Drug Deliv Transl Res; 2022 Dec; 12(12):3007-3016. PubMed ID: 35441321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection.
    Dampalla CS; Zheng J; Perera KD; Wong LR; Meyerholz DK; Nguyen HN; Kashipathy MM; Battaile KP; Lovell S; Kim Y; Perlman S; Groutas WC; Chang KO
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34210738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic and Antagonistic Drug Combinations against SARS-CoV-2.
    Bobrowski T; Chen L; Eastman RT; Itkin Z; Shinn P; Chen CZ; Guo H; Zheng W; Michael S; Simeonov A; Hall MD; Zakharov AV; Muratov EN
    Mol Ther; 2021 Feb; 29(2):873-885. PubMed ID: 33333292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nisoldipine Inhibits Influenza A Virus Infection by Interfering with Virus Internalization Process.
    Huang Y; Li Y; Chen Z; Chen L; Liang J; Zhang C; Zhang Z; Yang J
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds.
    Tzou PL; Tao K; Nouhin J; Rhee SY; Hu BD; Pai S; Parkin N; Shafer RW
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32916958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
    Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyronaridine Protects against SARS-CoV-2 Infection in Mouse.
    Puhl AC; Gomes GF; Damasceno S; Godoy AS; Noske GD; Nakamura AM; Gawriljuk VO; Fernandes RS; Monakhova N; Riabova O; Lane TR; Makarov V; Veras FP; Batah SS; Fabro AT; Oliva G; Cunha FQ; Alves-Filho JC; Cunha TM; Ekins S
    ACS Infect Dis; 2022 Jun; 8(6):1147-1160. PubMed ID: 35609344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data.
    Rommasi F; Nasiri MJ; Mirsaiedi M
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4163-4173. PubMed ID: 34156698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.
    Shahzad F; Anderson D; Najafzadeh M
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aprotinin-induced inhibition of pandemic influenza virus A(H1N1) reproduction].
    Zhirnov OP; Klenk HD
    Vopr Virusol; 2011; 56(3):24-8. PubMed ID: 21786623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
    Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
    Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.